Assessment of effects of IR and IPC on activities of cytochrome P450 isozymes in rats by a five-drug cocktail approach

References

• Zawaira A, Ching LY, Coulson L, et al. An expanded, unified substrate recognition site map for mammalian cytochrome P450s: analysis of molecular interactions between 15 mammalian CYP450 isoforms and 868 substrates. Curr Drug Metab 2011;12:684–700
   PubMed Web of Science ®Google Scholar
• Ogasawara A, Murakami Y, Yakushiji N, et al. Pharmacokinetic properties of newly synthesized retinoid X receptor agonists possessing a 6-[N-ethyl-N-(3-alkoxy-4-isopropylphenyl)amino]nicotinic acid skeleton in rats. Drug Dev Ind Pharm 2011;37:1060–7
   PubMed Web of Science ®Google Scholar
• Li Q, Wang R, Guo Y, et al. Relationship of CYP2D6 genetic polymorphisms and the pharmacokinetics of tramadol in Chinese volunteers. J Clin Pharm Ther 2010;35:239–47
   PubMed Web of Science ®Google Scholar
• Xia CH, Sun JG, Wang GJ, et al. Herb-drug interactions: in vivo and in vitro effect of Shenmai injection, a herbal preparation, on the metabolic activities of hepatic cytochrome P450 3A1/2, 2C6, 1A2, and 2E1 in rats. Planta Med 2010;76:245–50
   PubMed Web of Science ®Google Scholar
• Tanaka E, Kurata N, Yasuhara H. How useful is the “cocktail approach” for evaluating human hepatic drug metabolizing capacity using cytochrome P450 phenotyping probes in vivo? J Clin Pharm Ther 2003;28:157–65
   PubMed Web of Science ®Google Scholar
• Goh BC, Reddy NJ, Dandamudi UB, et al. An evaluation of the drug interaction potential of pazopanib, an oral vascular endothelial growth factor receptor tyrosine kinase inhibitor, using a modified Cooperstown 5 + 1 cocktail in patients with advanced solid tumors. Clin Pharmacol Ther 2010;88:652–9
   PubMed Web of Science ®Google Scholar
• Liu Y, Jiao J, Zhang C, Lou J. A simplified method to determine five cytochrome p450 probe drugs by HPLC in a single run. Biol Pharm Bull 2009;32:717–20
   PubMed Web of Science ®Google Scholar
• Verweij M, van Ginhoven TM, Mitchell JR, et al. Preoperative fasting protects mice against hepatic ischemia/reperfusion injury: mechanisms and effects on liver regeneration. Liver Transpl 2011;17:695–704
   PubMed Web of Science ®Google Scholar
• Cho KH, Lee SM. Altered activity of cytochrome P450 in alcoholic fatty liver exposed to ischemia/reperfusion. Arch Pharm Res 2007;30:50–7
   PubMed Web of Science ®Google Scholar
• Wang BY, Li QX, Li J, et al. Hepatotoxicity and gene expression down-regulation of CYP isozymes caused by renal ischemia/reperfusion in the rat. Exp Toxicol Pathol 2009;61:169–76
   PubMed Web of Science ®Google Scholar
• Ishihara Y, Sekine M, Hamaguchi A, et al. Effects of sulfaphenazole derivatives on cardiac ischemia-reperfusion injury: association of cytochrome P450 activity and infarct size. J Pharmacol Sci 2010;113:335–42
   PubMed Web of Science ®Google Scholar
• Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124–36
   PubMed Web of Science ®Google Scholar
• Koti RS, Seifalian AM, Davidson BR. Protection of the liver by ischemic preconditioning: a review of mechanisms and clinical applications. Dig Surg 2003;20:383–96
   PubMed Web of Science ®Google Scholar
• Gottlieb RA. Cytochrome P450: major player in reperfusion injury. Arch Biochem Biophys 2003;420:262–7
   PubMed Web of Science ®Google Scholar
• Nithipatikom K, Endsley MP, Moore JM, et al. Effects of selective inhibition of cytochrome P-450 omega-hydroxylases and ischemic preconditioning in myocardial protection. Am J Physiol Heart Circ Physiol 2006;290:H500–5
   PubMed Web of Science ®Google Scholar
• Ohmori M, Miyashita F, Uchida H, et al. Effect of erythromycin on ischemia-reperfusion injury of liver in rats. Transplant Proc 2000;32:811–14
   PubMed Web of Science ®Google Scholar
• Jin LM, Liu YX, Zhou L, et al. Ischemic preconditioning attenuates morphological and biochemical changes in hepatic ischemia/reperfusion in rats. Pathobiology 2010;77:136–46
   PubMed Web of Science ®Google Scholar
• Grezzana F, Tomaz de JM, Mendonça TB, et al. Topical hepatic hypothermia plus ischemic preconditioning: analysis of bile flow and ischemic injuries after initial reperfusion in rats. Acta Cir Bras 2011;26:194–201
   PubMed Web of Science ®Google Scholar
• Park CM, Cha YS, Youn HJ, et al. Amelioration of oxidative stress by dandelion extract through CYP2E1 suppression against acute liver injury induced by carbon tetrachloride in sprague-dawley rats. Phytother Res 2010;24:1347–53
   PubMed Web of Science ®Google Scholar
• Wójcikowski J, Daniel WA. The role of the nervous system in the regulation of liver cytochrome p450. Curr Drug Metab 2011;12:124–38
   PubMed Web of Science ®Google Scholar
• Challa VR, Ravindra Babu P, Challa SR, et al. Pharmacokinetic interaction study between quercetin and valsartan in rats and in vitro models. Drug Dev Ind Pharm 2012. [Epub ahead of print], doi:10.3109/03639045.2012.693502
   Google Scholar
• FDA Guidance for Industry: Drug interaction studies – study design, data analysis, and implications for dosing and labeling recommendations. Draft Guidance. 2012, 2. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM292362.pdf [last accessed 8 Jan 2013]
   Google Scholar
• Theodoraki K, Tympa A, Karmaniolou I, et al. Ischemia/reperfusion injury in liver resection: a review of preconditioning methods. Surg Today 2011;41:620–9
   PubMed Web of Science ®Google Scholar
• Selzner N, Liu H, Boehnert MU, et al. FGL2/Fibroleukin mediates hepatic reperfusion injury by induction of sinusoidal endothelial cell and hepatocyte apoptosis in mice. J Hepatol 2012;56:153–9
   PubMed Web of Science ®Google Scholar
• Friedrich D, Elisabeth T, Alexandra KK, et al. Bcl-2 upregulation after 3-nitropropionic acid preconditioning in warm rat liver ischemia. Shock 2008;30:699–704
   PubMed Web of Science ®Google Scholar